These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

747 related articles for article (PubMed ID: 11719448)

  • 41. Effects of boron neutron capture therapy on human oral squamous cell carcinoma in a nude mouse model.
    Kamida A; Obayashi S; Kato I; Ono K; Suzuki M; Nagata K; Sakurai Y; Yura Y
    Int J Radiat Biol; 2006 Jan; 82(1):21-9. PubMed ID: 16546900
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of sodium borocaptate with or without blood-brain barrier disruption.
    Yang W; Barth RF; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):663-72. PubMed ID: 9112465
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of 4-borono-2-18F-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model.
    Wang HE; Liao AH; Deng WP; Chang PF; Chen JC; Chen FD; Liu RS; Lee JS; Hwang JJ
    J Nucl Med; 2004 Feb; 45(2):302-8. PubMed ID: 14960653
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neutron capture therapy with a new boron-porphyrin compound in the rat 9L glioma model.
    Shibata Y; Matsumura A; Yamamoto T; Nakagawa K; Yoshii Y; Nose T; Sakata I; Nakajima S; Hayakawa Y; Ono K
    J Exp Clin Cancer Res; 1998 Sep; 17(3):285-9. PubMed ID: 9894763
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy.
    Dagrosa MA; Viaggi M; Rebagliati RJ; Batistoni D; Kahl SB; Juvenal GJ; Pisarev MA
    Mol Pharm; 2005; 2(2):151-6. PubMed ID: 15804189
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.
    Futamura G; Kawabata S; Nonoguchi N; Hiramatsu R; Toho T; Tanaka H; Masunaga SI; Hattori Y; Kirihata M; Ono K; Kuroiwa T; Miyatake SI
    Radiat Oncol; 2017 Jan; 12(1):26. PubMed ID: 28114947
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative assessment of single-dose and fractionated boron neutron capture therapy.
    Coderre JA; Morris GM; Micca PL; Fisher CD; Ross GA
    Radiat Res; 1995 Dec; 144(3):310-7. PubMed ID: 7494875
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro and in vivo evaluation of carboranyl uridines as boron delivery agents for neutron capture therapy.
    Liu L; Barth RF; Tjarks W; Soloway AH; Anisuzzaman AK
    Anticancer Res; 1996; 16(1):113-20. PubMed ID: 8615595
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dynamic SIMS ion microscopy imaging of intracellular boron accumulation from carboranyl nucleosides in glioma cells.
    Gay I; Lorey DR; Schinazi RF; Morrison GH; Chandra S
    Anticancer Res; 2001; 21(4A):2369-75. PubMed ID: 11724295
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Accumulation of boron in malignant and normal cells incubated in vitro with boronophenylalanine, mercaptoborane or boric acid.
    Capala J; Makar MS; Coderre JA
    Radiat Res; 1996 Nov; 146(5):554-60. PubMed ID: 8896582
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo (19)F MRI and (19)F MRS of (19)F-labelled boronophenylalanine-fructose complex on a C6 rat glioma model to optimize boron neutron capture therapy (BNCT).
    Porcari P; Capuani S; D'Amore E; Lecce M; La Bella A; Fasano F; Campanella R; Migneco LM; Pastore FS; Maraviglia B
    Phys Med Biol; 2008 Dec; 53(23):6979-89. PubMed ID: 19001698
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rat brain tumor models to assess the efficacy of boron neutron capture therapy: a critical evaluation.
    Barth RF; Yang W; Coderre JA
    J Neurooncol; 2003; 62(1-2):61-74. PubMed ID: 12749703
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer.
    Dagrosa MA; Thomasz L; Longhino J; Perona M; Calzetta O; Blaumann H; Rebagliati RJ; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1059-66. PubMed ID: 17967301
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Boron neutron capture therapy (BNCT) inhibits tumor development from precancerous tissue: an experimental study that supports a potential new application of BNCT.
    Monti Hughes A; Heber EM; Pozzi E; Nigg DW; Calzetta O; Blaumann H; Longhino J; Nievas SI; Aromando RF; Itoiz ME; Trivillin VA; Schwint AE
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S313-7. PubMed ID: 19376711
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular targeting and treatment of an epidermal growth factor receptor-positive glioma using boronated cetuximab.
    Wu G; Yang W; Barth RF; Kawabata S; Swindall M; Bandyopadhyaya AK; Tjarks W; Khorsandi B; Blue TE; Ferketich AK; Yang M; Christoforidis GA; Sferra TJ; Binns PJ; Riley KJ; Ciesielski MJ; Fenstermaker RA
    Clin Cancer Res; 2007 Feb; 13(4):1260-8. PubMed ID: 17317838
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biodistribution of (10)B for Boron Neutron Capture Therapy (BNCT) in a mouse model after injection of sodium mercaptoundecahydro-closo-dodecaborate and l-para-boronophenylalanine.
    Wittig A; Huiskamp R; Moss RL; Bet P; Kriegeskotte C; Scherag A; Hilken G; Sauerwein WA
    Radiat Res; 2009 Oct; 172(4):493-9. PubMed ID: 19772470
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Boron neutron capture therapy of brain tumors: functional and neuropathologic effects of blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
    Yang W; Barth RF; Rotaru JH; Boesel CP; Wilkie DA; Bresnahan JC; Hadjiconstantinou M; Goettl VM; Joel DD; Nawrocky MM
    J Neurooncol; 2000 Jul; 48(3):179-90. PubMed ID: 11100816
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo 19F MR imaging and spectroscopy for the BNCT optimization.
    Porcari P; Capuani S; D'Amore E; Lecce M; La Bella A; Fasano F; Migneco LM; Campanella R; Maraviglia B; Pastore FS
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S365-8. PubMed ID: 19375924
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Boron neutron capture therapy of intracerebral melanoma using boronophenylalanine as a capture agent.
    Matalka KZ; Bailey MQ; Barth RF; Staubus AE; Soloway AH; Moeschberger ML; Coderre JA; Rofstad EK
    Cancer Res; 1993 Jul; 53(14):3308-13. PubMed ID: 8324742
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neutron capture therapy of intracerebral melanoma: enhanced survival and cure after blood-brain barrier opening to improve delivery of boronophenylalanine.
    Barth RF; Yang W; Bartus RT; Rotaru JH; Ferketich AK; Moeschberger ML; Nawrocky MM; Coderre JA; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):858-68. PubMed ID: 11849812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.